ValueAct Buys 3M Valeant Pharma (VRX) Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Valeant Pharma (VRX) Director De Schutter Buys 10K Shares
March 16, 2017 5:17 PM EDTValeant Pharma (NYSE: VRX) Director, Richard De Schutter, bought 10,000 shares on 03/15 at $10.80
... MoreValeant Pharma (VRX) CFO Buys 24K Shares
March 16, 2017 5:09 PM EDTValeant Pharma (NYSE: VRX) CFO Paul Herendeen disclosed buying 24,000 shares on 03/14 at $10.72, bringing his stake to 174,000 shares.
The disclosure from Herendeen follows the 3 million share purchase from large and noted investor group ValueAct capital.
FORM... More
